Winton Group’s KALA BIO KALA Stock Holding History

Winton Group’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6	Closed	-$83K	–	1410
2021 Q2	$83K	Sell	6 -6	-50%	-$94.3K	﹤0.01%	1391
2021 Q1	$200K	Buy	+12	New	+$234K	0.01%	1288

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Winton Group's KALA Position: Q3 2021 in Review

Winton Group sold out of KALA BIO (KALA) in Q3 2021, closing a stake of 6 shares — an estimated $83K sold.

Winton Group first reported a position in KALA in Q1 2021 and held it in 2 quarters. The position peaked at $200K in Q1 2021. 99 funds tracked by Wall St. Rank hold KALA as of Q3 2021.

Winton Group reported no remaining KALA BIO position as of Q3 2021 after selling out during the quarter.
Winton Group sold 6 KALA BIO shares in Q3 2021, an estimated $83K.
Winton Group first reported a position in KALA BIO in Q1 2021 and held it in 2 quarters.
Winton Group's KALA BIO position peaked at $200K in Q1 2021.
99 funds tracked by Wall St. Rank held KALA BIO as of Q3 2021.

Based on Winton Group's 13F filing for Q3 2021, filed 28 Oct 2021.